Free Trial

Nektar Therapeutics (NKTR) SEC Filings & 10K Form

Nektar Therapeutics logo
$1.40 +0.03 (+1.82%)
(As of 11:18 AM ET)

Recent Nektar Therapeutics SEC Filings

DateFilerForm TypeView
11/04/2024
7:52 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
8:15 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
8:15 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
8:14 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
3:13 PM
Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
2:45 PM
Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
5:02 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
11:15 PM
Nektar Therapeutics (Filer)
Form EFFECT
06/05/2024
4:30 PM
Nektar Therapeutics (Filer)
Form 424B3
05/28/2024
3:51 PM
Nektar Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/20/2024
8:12 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
8:13 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
8:14 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:36 PM
Deep Track Biotechnology Master Fund, Ltd. (Reporting)
Deep Track Capital, LP (Reporting)
KROIN DAVID (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:20 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:12 PM
Nektar Therapeutics (Filer)
Form ARS
04/17/2024
4:03 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
3:38 PM
Nektar Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
03/15/2024
3:18 PM
Nektar Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
03/14/2024
3:30 PM
Deep Track Biotechnology Master Fund, Ltd. (Reporting)
Deep Track Capital, LP (Reporting)
KROIN DAVID (Reporting)
Nektar Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/05/2024
4:11 PM
Nektar Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2024
3:20 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
7:40 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
7:16 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:17 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:19 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
2:50 PM
Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
2:51 PM
Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
4:16 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:50 AM
Deep Track Capital, LP (Filed by)
Nektar Therapeutics (Subject)
Form SC 13G/A
01/10/2024
3:25 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
5:05 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
5:05 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
5:07 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
11:18 AM
Nektar Therapeutics (Subject)
WHITFIELD ROY A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2023
3:55 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023
7:58 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
8:00 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
8:02 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
3:36 PM
Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2023
3:21 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NKTR) was last updated on 11/8/2024 by MarketBeat.com Staff
From Our Partners